Although this hypothesis might not be sufficient to explain the extremely poor prognosis in this group of patients, it does point to a specific tumor composition in which T- and E-STAT3 are coordinated to provide tumor cells with a proliferation advantage compared to patients that do not display high T- and E-STAT3 activity. This evidence concerns the gene STAT3 and neoplasm.